Verified Supplement Data Primary-sourced

Astaxanthin Side Effects: Why It Is Unusually Well Tolerated

By Erin Rose · Published · Reviewed against primary sources · Methodology · About Us

Informational summary of published research — not medical advice. Most astaxanthin safety data comes from short trials (4–12 weeks) at 4–12mg/day; very high or long-term dosing is not well studied. If you take blood thinners, antiplatelet or blood pressure medication, or are pregnant or breastfeeding, check with a doctor before starting. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Astaxanthin's human safety record is genuinely clean. The trials that exist — mostly 4–12mg/day for 4–12 weeks — report no serious adverse events, and one dyspepsia trial found no more GI symptoms at 40mg/day than at placebo. What's actually worth knowing: the harmless-but-alarming pigment effects (orange or pink stool, and anecdotally skin tint at high doses), a theoretical blood-pressure and blood-thinning interaction with no confirmed effect at commercial doses, and 5-alpha-reductase/hormone claims that rest on one in-vitro assay and one confounded combination-supplement trial — not astaxanthin-alone human data. Pregnancy and breastfeeding safety hasn't been studied at all, so the usual caution applies. Doses well above the 4–12mg most products use are essentially untested.

Looking for a tested product? See our best astaxanthin ranked by cost per mg, which also covers the branded-extract and source questions →

The honest headline: a clean record, from short trials

Across the human trials behind astaxanthin's benefit claims, the safety data is consistently unremarkable. A 4-week trial of 12mg/day in healthy adults, run to measure choroidal blood flow, reported no subjective or objective adverse events at all (Saito 2012, PMID: 22072378). A systematic review of clinical trials testing astaxanthin for skin health, mostly at 3–6mg/day, likewise reported no serious adverse events across the studies it covered (Ng 2021, PMID: 32202443). The broadest safety review available, covering 87 human studies of natural astaxanthin at doses from 2 to 24mg/day (35 of them at 12mg/day or higher), found no safety signal across that range (Brendler 2019, PMID: 31788888) — the same review behind the site's dosage guidance that the widely-cited "2mg EFSA limit" comes from a synthetic-astaxanthin rat study and doesn't apply to the natural, algae-derived supplement sold today (see natural vs. synthetic).

On the specific question of GI upset, a 4-week, 132-person trial in people with functional dyspepsia randomized to placebo, 16mg/day, or 40mg/day found no difference in gastrointestinal symptom scores between any of the three groups — covering abdominal pain, indigestion, and reflux (Kupcinskas 2008, PMID: 18467083). The 40mg/day dose in that trial is well above the 4–12mg most commercial products use, which makes the null result on GI symptoms more reassuring, not less — the highest dose actually tested in a controlled trial didn't produce more stomach complaints than sugar pills. None of this means side effects never happen to any individual; it means the trial record doesn't show them happening more than chance. Astaxanthin is fat-soluble, so taking it with a meal that contains some fat is standard practical advice for absorption, independent of any tolerability claim.

Harmless but alarming: skin and stool tint

Astaxanthin is, chemically, a concentrated red-orange pigment. Because a portion of any oral dose isn't absorbed and passes through the gut, some people notice their stool turn pink or orange — the carotenoid itself becoming visible, not a sign anything is wrong. A similar, milder pink-orange tint to the skin is reported anecdotally at high, sustained doses, the same pigment effect showing up in a different place. Read that carefully, though: none of the controlled trials reviewed for this page — including a systematic review built specifically around skin-health outcomes at 3–6mg/day (Ng 2021) — documented skin discoloration as an adverse event. That could mean it's genuinely rare at studied doses, or that trial doses (mostly under 12mg/day) sit below whatever threshold produces a visible tint. Either way, treat it as a plausible, cosmetic, non-dangerous possibility rather than a documented trial finding, and don't confuse it with retinal pigment changes reported for a different carotenoid (canthaxanthin) used at very high doses in older tanning-pill products — that is a distinct compound with its own separate safety record, not astaxanthin.

Blood pressure and blood thinning: a plausible mechanism, no confirmed human effect

The animal and human data on this point disagree, and the human data is what matters more. In hyperlipidemic rats given oral astaxanthin at 5, 10, or 30mg/kg/day for four weeks, the highest dose reduced blood coagulation and platelet aggregation and increased fibrinolytic (clot-dissolving) activity, measured directly via coagulation-panel and platelet-aggregation assays (Deng 2017, PMID: 27951728) — animal data, at a per-kilogram dose that doesn't translate directly into a human milligram amount. Separately, when a synthetic astaxanthin-derived compound was mixed directly with blood samples from human volunteers, across a concentration range running from below physiologic levels up to supratherapeutic, it had no measurable effect on any of 25 platelet, coagulation, or fibrinolysis biomarkers tested, in either aspirin-naive or aspirin-treated subjects (Serebruany 2010, PMID: 20305399). That study used a synthetic derivative, not the natural algal extract sold as a supplement, so it doesn't settle the question either — but it's the closest thing to direct human platelet data that exists, and it found nothing.

On blood pressure specifically, the one trial in this evidence base that measured it as an outcome — women with PCOS taking 12mg/day for 8 weeks — reported significant improvements in insulin resistance, lipid markers, and oxidative stress, but did not report a significant change in blood pressure (Jabarpour 2024, PMID: 37874168). Put together: there's a real, mechanistically plausible signal in animal platelet data, and no confirmed effect on blood pressure or clotting in the human data available at commercial doses. That gap — plausible but unconfirmed — is exactly why this is a "talk to your doctor first" caution rather than a settled interaction: if you take anticoagulants, antiplatelet drugs (including daily aspirin), or blood pressure medication, mention astaxanthin before starting, since the absence of a confirmed human effect isn't the same as a ruled-out one.

5-alpha-reductase, hormones, and pregnancy caution

Astaxanthin sometimes gets marketed alongside DHT-blocking or hair-loss claims. The evidence behind that is thin and mostly doesn't come from a living body: in a cell-culture assay, astaxanthin inhibited the 5-alpha-reductase enzyme (the one that converts testosterone to DHT) by 98% at a concentration of 300 micrograms/mL, and separately slowed the growth of a prostate cancer cell line in the same dish (Anderson 2005, PMID: 16093232). That's an enzyme-inhibition result in a test tube, not a measured hormonal effect in a person, and the study makes no claim about what concentration oral supplementation actually reaches in human tissue.

The one human hormone trial that exists doesn't isolate astaxanthin either. Twenty sedentary men took a combination supplement of astaxanthin plus saw palmetto berry extract (Resettin/MyTosterone) at 800mg or 1200mg of the combined product per day, in a 14-day crossover design. Both doses significantly lowered DHT versus placebo, and the 1200mg dose also significantly lowered estradiol; testosterone rose 38% but didn't reach statistical significance (Anderson 2014, PMID: 25183955). Because it's a two-ingredient blend dosed as a whole — not a stated astaxanthin-only amount — this trial cannot show what astaxanthin alone contributed, if anything. Call the DHT/5-alpha-reductase claim weak, not disproven: real published data exists, but none of it isolates and confirms an effect from astaxanthin by itself in the human body.

That same gap in isolated human hormone data is why pregnancy and breastfeeding get a hard caution rather than a specific warning: no dedicated trial has tested astaxanthin supplementation in pregnant or breastfeeding people at any dose. That's an absence of safety data, not evidence that it's fine — the standard, conservative approach is to avoid it, or check with a doctor first, during pregnancy or while nursing.

Astaxanthin side effects at a glance

Astaxanthin safety questions, what the evidence actually shows, and who it matters to
QuestionWhat the evidence showsStrengthWho it matters to
GI upsetNo difference vs. placebo at 16–40mg/day (Kupcinskas 2008); no adverse events at 12mg/day (Saito 2012)Reassuring — even the highest tested dose showed nothingAnyone using commercial 4–12mg doses
Stool / skin tintPigment passes through unabsorbed (stool); skin tint reported anecdotally at high doses, not documented in trialsPlausible, harmless, not formally studiedHigh-dose, long-term users
Blood pressureThe one trial that measured it directly (12mg/8wk) found no significant changeNo confirmed human effect at commercial doseAnyone on BP medication, as a precaution
Blood thinning / plateletsReduced platelet aggregation & coagulation in rats (30mg/kg); no effect in human blood in vitro (synthetic derivative)Animal signal, human data null but indirectAnyone on anticoagulants, antiplatelets, or aspirin
5-alpha-reductase / DHT98% inhibition in a cell-culture assay; DHT lowered in a confounded astaxanthin+saw-palmetto blend trialWeak — not isolated to astaxanthin in humansAnyone relying on hair-loss/BPH marketing claims
Pregnancy / breastfeedingNo dedicated human trials found at any doseAbsence of data, not evidence of safetyPregnant or nursing

Compare Astaxanthin Products by Cost Per Day

If you're ready to buy, here's how the astaxanthin products we track and verify compare on cost per day.

Ranked by cost per day, lowest first — from the Verified Supplement Data catalog, prices reviewed August 2026.
ProductDose/ServingServingsPriceCost/DayCertificationBuy
NOW Foods Astaxanthin 4 mg (Zanthin)
Best Value
4mg astaxanthin90$14.11$0.16None statedBuy on Amazon
Nutricost Astaxanthin 12 mg
12mg astaxanthin120$27.95$0.23None statedBuy on Amazon
Sports Research Triple Strength Astaxanthin 12 mg
12mg astaxanthin60$26.95$0.44None statedBuy on Amazon
Nutrex Hawaii BioAstin 12 mg
12mg astaxanthin50$31.99$0.64None statedBuy on Amazon

Frequently asked questions

What is the most common astaxanthin side effect?

In the controlled trials that exist, nothing shows up more often than placebo. A 4-week trial of 12mg/day found no subjective or objective adverse events at all (Saito 2012), and a 4-week dyspepsia trial comparing placebo against 16mg and 40mg/day found no difference in gastrointestinal symptom scores between any of the three groups (Kupcinskas 2008) — meaning even the highest dose formally tested in a controlled trial didn't produce more GI complaints than placebo. Most human data sits at 4-12mg/day; doses much higher than that are essentially untested for tolerability specifically.

Can astaxanthin turn your skin or stool orange or pink?

Stool color, yes — astaxanthin is a red-orange pigment, a portion of any oral dose isn't absorbed, and what passes through can tint stool pink or orange. That's the pigment showing up, not a sign of harm. A mild pink-orange skin tint at high, sustained doses is also reported anecdotally, the same pigment effect showing in skin instead — but it doesn't appear as a documented adverse event in the astaxanthin trials reviewed for this page, including a systematic review specifically covering skin-health trials (Ng 2021). Treat it as a plausible, harmless, but not formally studied cosmetic effect, not a symptom to worry about.

Does astaxanthin thin the blood or lower blood pressure?

The honest answer is: plausible mechanism, no confirmed human effect at typical doses. In hyperlipidemic rats given 30mg/kg/day, astaxanthin reduced platelet aggregation and blood coagulation and increased fibrinolytic activity (Deng 2017) — but that's animal data at a dose that doesn't translate directly to a human mg amount. When a synthetic astaxanthin-derived compound was mixed directly with human blood samples in vitro, across a range up to supratherapeutic concentrations, it did not affect platelet aggregation, coagulation, or fibrinolytic markers in either aspirin-naive or aspirin-treated volunteers (Serebruany 2010). On blood pressure specifically, the one trial in this evidence base that measured it directly — 12mg/day for 8 weeks in women with PCOS — reported significant improvements in insulin resistance and lipids but no significant blood pressure change (Jabarpour 2024). If you take blood thinners, antiplatelet medication (including aspirin), or blood pressure medication, mention astaxanthin to your doctor anyway; unconfirmed at typical doses isn't the same as ruled out.

Does astaxanthin block DHT or affect hormones, and is it safe in pregnancy?

The DHT-blocking claim rests on thin evidence. In a cell-culture assay, astaxanthin inhibited the 5-alpha-reductase enzyme by 98% at 300 micrograms/mL and slowed prostate cancer cell growth in the same dish (Anderson 2005) — an in-vitro concentration, not a measured effect in a living body. The one human hormone trial doesn't isolate astaxanthin either: a combination supplement of astaxanthin plus saw palmetto extract, given to 20 sedentary men at 800 or 1200mg of the blend per day, significantly lowered DHT (and, at the higher dose, estradiol) versus placebo, while testosterone rose 38% without reaching statistical significance (Anderson 2014). Because that's a two-ingredient blend dosed as a whole, it can't show what astaxanthin alone did. No dedicated trial has tested astaxanthin supplementation in pregnant or breastfeeding people at all — that's an absence of data, not evidence of safety, so the standard precaution is to avoid it or check with a doctor first.

Related guides

Sources

  1. Saito M, et al. "Astaxanthin increases choroidal blood flow velocity." Graefes Arch Clin Exp Ophthalmol. 2012;250(2):239-45. PMID: 22072378
  2. Ng QX, et al. "Effects of Astaxanthin Supplementation on Skin Health: A Systematic Review of Clinical Studies." J Diet Suppl. 2021;18(2):169-182. PMID: 32202443
  3. Brendler T, Williamson EM. "Astaxanthin: how much is too much? A safety review." Phytother Res. 2019;33(12):3090-3111. PMID: 31788888
  4. Kupcinskas L, et al. "Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection." Phytomedicine. 2008;15(6-7):391-9. PMID: 18467083
  5. Deng ZY, et al. "Effects of astaxanthin on blood coagulation, fibrinolysis and platelet aggregation in hyperlipidemic rats." Pharm Biol. 2017;55(1):663-672. PMID: 27951728 (animal study)
  6. Serebruany V, et al. "The in vitro effects of Xancor, a synthetic astaxanthine derivative, on hemostatic biomarkers in aspirin-naive and aspirin-treated subjects with multiple risk factors for vascular disease." Am J Ther. 2010;17(2):125-32. PMID: 20305399
  7. Jabarpour M, et al. "Astaxanthin supplementation impact on insulin resistance, lipid profile, blood pressure, and oxidative stress in polycystic ovary syndrome patients: A triple-blind randomized clinical trial." Phytother Res. 2024;38(1):321-330. PMID: 37874168
  8. Anderson ML. "A preliminary investigation of the enzymatic inhibition of 5alpha-reduction and growth of prostatic carcinoma cell line LNCap-FGC by natural astaxanthin and Saw Palmetto lipid extract in vitro." J Herb Pharmacother. 2005;5(1):17-26. PMID: 16093232 (in vitro)
  9. Anderson ML. "Evaluation of Resettin® on serum hormone levels in sedentary males." J Int Soc Sports Nutr. 2014;11:43. PMID: 25183955 (astaxanthin + saw palmetto combination product)